The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics
Open accessAbstract
Glucuronidation mediated by UDP-glucuronosyltransferases (UGTs) is a significant metabolic pathway that facilitates efficient elimination of numerous endo- and xenobiotics including phenolics. UGT genetic deficiency and polymorphisms or inhibition of glucuronidation by concomitant use of drugs are associated with inherited physiological disorders or drug induced toxicities. Moreover, extensive glucuronidation can be a barrier to oral bioavailability as the first-pass glucuronidation (or premature clearance by UGTs) of orally administered agents usually results in the poor oral bioavailability and lack of efficacies. This review focused on the first-pass glucuronidation of phenolics including natural polyphenols and pharmaceuticals. The complexity of UGT-mediated metabolism of phenolics is highlighted with species-, gender-, organ- and isoform-dependent specificity, as well as functional compensation between UGT1A and 2B subfamily. In addition, recent advances are discussed with respect to the mechanisms of enzymatic actions including the important properties such as binding pocket size and phosphorylation requirements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D IETARY F LAVONOIDS: Bioavailability, Metabolic Effects, and Safety
Ross, J. A., & Kasum, C. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.111401.144957 · Cited by 2,151
Dietary phenolics: chemistry, bioavailability and effects on health
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009) · Natural Product Reports · doi:10.1039/b802662a · Cited by 1,988
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Birt, D. F., Hendrich, S., & Wang, W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00137-1 · Cited by 1,171
Setchell, K. D. R., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., Kirschner, A. S., Cassidy, A., & Heubi, J. E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.4.1362s · Cited by 973
Beutler, E., Gelbart, T., & Demina, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8170 · Cited by 853
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S.-I., Iyanagi, T., Miners, J. O., Owens, I. S., & Nebert, D. W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000173483.13689.56 · Cited by 821
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)
Garcia-Calvo, M., Lisnock, J., Bull, H. G., Hawes, B. E., Burnett, D. A., Braun, M. P., Crona, J. H., Davis, H. R., Dean, D. C., Detmers, P. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500269102 · Cited by 670
Desta, Z., Ward, B. A., Soukhova, N. V., & Flockhart, D. A. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065607 · Cited by 645
Resveratrol bioavailability and toxicity in humans
Cottart, C., Nivet‐Antoine, V., Laguillier‐Morizot, C., & Beaudeux, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900437 · Cited by 592
Higher plant glycosyltransferases.
Ross, J., Li, Y., Lim, E., & Bowles, D. J. (2001) · Genome biology · doi:10.1186/gb-2001-2-2-reviews3004 · Cited by 533
GLYCOSYLTRANSFERASES OF LIPOPHILIC SMALL MOLECULES
Bowles, D., Lim, E.-K., Poppenberger, B., & Vaistij, F. E. (2006) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.57.032905.105429 · Cited by 529
STRUCTURAL AND FUNCTIONAL STUDIES OF UDP-GLUCURONOSYLTRANSFERASES*
RADOMINSKA-PANDYA, A., CZERNIK, P. J., LITTLE, J. M., BATTAGLIA, E., & MACKENZIE, P. I. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101944 · Cited by 497
Marier, J.-F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J.-P., & Ducharme, M. P. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033340 · Cited by 480
Ezetimibe: A Review of its Metabolism, Pharmacokinetics and Drug Interactions
Kosoglou, T., Statkevich, P., Johnson-Levonas, A. O., Paolini, J. F., Bergman, A. J., & Alton, K. B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544050-00002 · Cited by 476
Offen, W., Martinez‐Fleites, C., Yang, M., Kiat‐Lim, E., Davis, B. G., Tarling, C. A., Ford, C. M., Bowles, D. J., & Davies, G. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600970 · Cited by 470
Manach, C., Morand, C., Gil-Izquierdo, A., Bouteloup-Demange, C., & Rémésy, C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601547 · Cited by 460
Kinetics and metabolism of paracetamol and phenacetin.
Prescott, L. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01812.x · Cited by 454
Ohno, S., & Nakajin, S. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023598 · Cited by 428
King, R., & Bursill, D. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.867 · Cited by 410
Beer constituents as potential cancer chemopreventive agents
Gerhäuser, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.012 · Cited by 408
Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions
Ritter, J. K. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00198-8 · Cited by 386
Shao, H., He, X., Achnine, L., Blount, J. W., Dixon, R. A., & Wang, X. (2005) · The Plant Cell · doi:10.1105/tpc.105.035055 · Cited by 385
Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability
Wen, X., & Walle, T. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011122 · Cited by 377
The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†
Fisher, M. B., Paine, M. F., Strelevitz, T. J., & Wrighton, S. A. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000653 · Cited by 375
Uchaipichat, V., Mackenzie, P. I., Guo, X.-H., Gardner-Stephen, D., Galetin, A., Houston, J. B., & Miners, J. O. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.4.413 · Cited by 335
Van Heek, M., Farley, C., Compton, D. S., Hoos, L., Alton, K. B., Sybertz, E. J., & Davis, H. R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703235 · Cited by 326
Brazier-Hicks, M., Offen, W. A., Gershater, M. C., Revett, T. J., Lim, E.-K., Bowles, D. J., Davies, G. J., & Edwards, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706421104 · Cited by 320
On the origin of family 1 plant glycosyltransferases
Paquette, S., Møller, B. L., & Bak, S. (2003) · Phytochemistry · doi:10.1016/s0031-9422(02)00558-7 · Cited by 305
Metabolism of Green Tea Catechins: An Overview
Yong Feng, W. (2006) · Current Drug Metabolism · doi:10.2174/138920006778520552 · Cited by 301
Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines
Nakamura, A., Nakajima, M., Yamanaka, H., Fujiwara, R., & Yokoi, T. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021428 · Cited by 286
Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent
Gopala, S., Babykutty, S., Sathiadevan, P. P., & Srinivas, P. (2006) · Medicinal Research Reviews · doi:10.1002/med.20095 · Cited by 286
Osmani, S. A., Bak, S., & Møller, B. L. (2009) · Phytochemistry · doi:10.1016/j.phytochem.2008.12.009 · Cited by 282
O’Leary, K. A., Day, A. J., Needs, P. W., Mellon, F. A., O’Brien, N. M., & Williamson, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01510-1 · Cited by 275
Zhang, Y., Song, T. T., Cunnick, J. E., Murphy, P. A., & Hendrich, S. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.2.399 · Cited by 267
Moon, J.-H., Tsushida, T., Nakahara, K., & Terao, J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00522-6 · Cited by 263
Liu, Y., & Hu, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.370 · Cited by 253
Self-citationThe fate of naringin in humans: A key to grapefruit juice-drug interactions?
Fuhr, U., & Kummert, A. L. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90048-9 · Cited by 252
Walle, U. K., Galijatovic, A., & Walle, T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00133-1 · Cited by 251
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Resveratrol Is Absorbed in the Small Intestine as Resveratrol Glucuronide
Kuhnle, G., Spencer, J. P. E., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K. S., Rice-Evans, C., & Hahn, U. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2750 · Cited by 249
Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition
Chen, J., Lin, H., & Hu, M. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046409 · Cited by 248
Self-citationBioavailability challenges associated with development of anti-cancer phenolics
Gao, S., & Hu, M. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384081 · Cited by 242
Self-citationAbsorption and enterohepatic circulation of baicalin in rats
Xing, J., Chen, X., & Zhong, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.04.072 · Cited by 230
Izukawa, T., Nakajima, M., Fujiwara, R., Yamanaka, H., Fukami, T., Takamiya, M., Aoki, Y., Ikushiro, S.-I., Sakaki, T., & Yokoi, T. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027227 · Cited by 230
Miners, J. O., Mackenzie, P. I., & Knights, K. M. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903210716 · Cited by 226
In vitro biological properties of flavonoid conjugates found in vivo
Williamson, G., Barron, D., Shimoi, K., & Terao, J. (2005) · Free Radical Research · doi:10.1080/10715760500053610 · Cited by 212
Stone, A. N., Mackenzie, P. I., Galetin, A., Houston, J. B., & Miners, J. O. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1086 · Cited by 206
Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans
DuPont, M. S., Day, A. J., Bennett, R. N., Mellon, F. A., & Kroon, P. A. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601916 · Cited by 205
Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats
Barve, A., Chen, C., Hebbar, V., Desiderio, J., Saw, C. L., & Kong, A. (2009) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.677 · Cited by 202
Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation.
Shimoi, K., Saka, N., Nozawa, R., Sato, M., Amano, I., Nakayama, T., & Kinae, N. (2001) · PubMed · Cited by 198
Miley, M. J., Zielinska, A. K., Keenan, J. E., Bratton, S. M., Radominska-Pandya, A., & Redinbo, M. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.066 · Cited by 198
Tissue- and Gender-Specific mRNA Expression of UDP-Glucuronosyltransferases (UGTs) in Mice
Buckley, D. B., & Klaassen, C. D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012070 · Cited by 198
Li, L., Modolo, L. V., Escamilla-Trevino, L. L., Achnine, L., Dixon, R. A., & Wang, X. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.036 · Cited by 195
Resveratrol transport and metabolism by human intestinal Caco-2 cells
Kaldas, M. I., Walle, U. K., & Walle, T. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702612 · Cited by 188
Tissue mRNA Expression of the Rat UDP-Glucuronosyltransferase Gene Family
Shelby, M. K., Cherrington, N. J., Vansell, N. R., & Klaassen, C. D. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.326 · Cited by 187
Absorption and Excretion of the Soy Isoflavone Genistein in Rats
King, R. A., Broadbent, J. L., & Head, R. J. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.1.176 · Cited by 183
Intestinal and Hepatic Glucuronidation of Flavonoids
Zhang, L., Zuo, Z., & Lin, G. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700077z · Cited by 182
Ehrhardt, C., & Kim, K. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3 · Cited by 181
Commentary: Bioavailability of Flavonoids and Polyphenols: Call to Arms
Hu, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp7001363 · Cited by 170
Self-citationO'Dwyer, P. J., & Catalano, R. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3031 · Cited by 166
Modolo, L. V., Li, L., Pan, H., Blount, J. W., Dixon, R. A., & Wang, X. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.08.017 · Cited by 161
Davis, H. R., & Veltri, E. P. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.99 · Cited by 160
Natural polyphenol disposition via coupled metabolic pathways
Liu, Z., & Hu, M. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.3.389 · Cited by 159
Self-citationBrett, G. M., Hollands, W. J., Needs, P. W., Teucher, B., Dainty, J. R., Davis, B. D., Brodbelt, J. S., & Kroon, P. A. (2008) · British Journal Of Nutrition · doi:10.1017/s000711450803081x · Cited by 152
Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers
Brand, W., van der Wel, P. A. I., Rein, M. J., Barron, D., Williamson, G., van BLADEREN, P. J., & Rietjens, I. M. C. M. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019943 · Cited by 146
Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits
Hsiu, S., Huang, T.-Y., Hou, Y., Chin, D., & Chao, P.-D. L. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01491-6 · Cited by 145
Ghosal, A., Hapangama, N., Yuan, Y., Achanfuo-Yeboah, J., Iannucci, R., Chowdhury, S. K., Alton, K. B., Patrick, J. E., & Zbáida, S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.314 · Cited by 143
Morphine‐6‐glucuronide: Actions and mechanisms
Kilpatrick, G. J., & Smith, T. W. (2005) · Medicinal Research Reviews · doi:10.1002/med.20035 · Cited by 143
Hu, M., Chen, J., & Lin, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053496 · Cited by 142
Self-citationPiver, B., Fer, M., Vitrac, X., Mérillon, J., Dréano, Y., Berthou, F., & Lucas, D. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.008 · Cited by 136
Mutlib, A. E., Goosen, T. C., Bauman, J. N., Williams, J. A., Kulkarni, S., & Kostrubsky, S. E. (2006) · Chemical Research in Toxicology · doi:10.1021/tx050317i · Cited by 135
Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status
Kèlland, L. R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2903 · Cited by 134
Matsumoto, H., Ikoma, Y., Sugiura, M., Yano, M., & Hasegawa, Y. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0491411 · Cited by 131
Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells
Galijatovic, A., Otake, Y., Walle, U. K., et al. (1999) · Xenobiotica · doi:10.1080/004982599237912 · Cited by 130
Regulation of UDP Glucuronosyltransferase Genes
Mackenzie, P. I., Gregory, P. A., Gardner-Stephen, D. A., et al. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489442 · Cited by 129
Bock, K. W. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.034 · Cited by 124
Chen, J., Lin, H., & Hu, M. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0842-x · Cited by 124
Self-citationLi, Z., Lin, G., & Zuo, Z. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9126-y · Cited by 123
Metabolic fate of luteolin and its functional activity at focal site
Shimoi, K., Saka, N., Kaji, K., & Nozawa, N. K. R. (2000) · BioFactors · doi:10.1002/biof.5520120129 · Cited by 118
Mechanistic study on the intestinal absorption and disposition of baicalein
Li, Z., Lin, G., Kalapos‐Kovács, B., Jani, M., Krajcsi, P., & Zuo, Z. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.04.001 · Cited by 116
Xiong, H., Turner, K. C., Ward, E. S., Jansen, P. L. M., & Brouwer, K. L. R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38933-5 · Cited by 115
Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
Otake, Y., Hsieh, F., & Walle, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.576 · Cited by 114
CODEINE ANALGESIA IS DUE TO CODEINE‐6‐GLUCURONIDE, NOT MORPHINE
Vree, T., van Dongen, R. T. M., & Koopman-Kimenai, P. M. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb11929.x · Cited by 111
Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems
Patel, M. M., Shah, T. J., & Amin, A. F. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.20 · Cited by 108
Glucuronidase Deconjugation in Inflammation
Shimoi, K., & Nakayama, T. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00015-7 · Cited by 107
Mizuma, T. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.044 · Cited by 106
AVE8062: a new combretastatin derivative vascular disrupting agent
Delmonte, A., & Sessa, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903213697 · Cited by 106
Jeong, E. J., Liu, X., Jia, X., Chen, J., & Hu, M. (2005) · Current Drug Metabolism · doi:10.2174/138920005774330657 · Cited by 105
Self-citationJia, X., Chen, J., Lin, H., & Hu, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068403 · Cited by 105
Self-citationXenobiotic Nuclear Receptor-Mediated Regulation of UDP-Glucuronosyltransferases
Zhou, J., Zhang, J., & Xie, W. L. (2005) · Current Drug Metabolism · doi:10.2174/1389200054633853 · Cited by 103
Pharmacokinetics of3H-phenylephrine in man
Hengstmann, J. H., & Goronzy, J. J. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637623 · Cited by 101
SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
Jeong, E. J., Liu, Y., Lin, H., & Hu, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001883 · Cited by 100
Self-citationKINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
Luukkanen, L., Taskinen, J., Kurkela, M. J., Kostiainen, R. K., Hirvonen, J. J., & Finel, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.004093 · Cited by 100
Brand, W., Boersma, M. G., Bik, H., den Hil, E. F. H.-V., Vervoort, J. J. M., Barron, D., Meinl, W., Glatt, H. R., Williamson, G., van BLADEREN, P. J., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031047 · Cited by 99
Regioselective and Stereospecific Glucuronidation of trans- and cis-Resveratrol in Human
Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Mérillon, J., Magdalou, J., & Sabolovic, N. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2496 · Cited by 97
Xu, H., Kulkarni, K. H., Singh, R., Yang, Z., Wang, S. W. J., Tam, V. H., & Hu, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900013d · Cited by 93
Self-citationWikberg, T., Vuorela, A., Ottoila, P., et al. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07341-6 · Cited by 90
Lautala, P., Ethell, B. T., Taskinen, J., & Burchell, B. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15088-x · Cited by 90
Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants
Sun, D., Chen, G., Dellinger, R. W., Duncan, K., Fang, J., & Lazarus, P. J. (2006) · Breast Cancer Research · doi:10.1186/bcr1539 · Cited by 89
In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
Boutin, J. A., Meunier, F. A., Lambert, P. H., Hennig, P., Bertin, D., Serkiz, B., & Volland, J. P. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08215-7 · Cited by 86
In vitro glucuronidation of kaempferol and quercetin by human UGT‐1A9 microsomes
Oliveira, E. D. J., & Watson, D. G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01355-7 · Cited by 85
UDP-Glucuronosyltransferases: Gene Structures of UGT1 and UGT2 Families
Owens, I. S., Basu, N. K., & Banerjee, R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00001-7 · Cited by 84
Barrington, R., Williamson, G., Bennett, R. N., Davis, B. D., Brodbelt, J. S., & Kroon, P. A. (2008) · Journal of Functional Foods · doi:10.1016/j.jff.2008.09.011 · Cited by 84
Zamek‐Gliszczynski, M. J., Hoffmaster, K. A., Humphreys, J. E., Tian, X., Nezasa, K.-I., & Brouwer, K. L. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101840 · Cited by 81
DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION
Chen, J., Wang, S., Jia, X., Bajimaya, S., Lin, H., Tam, V. H., & Hu, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003673 · Cited by 80
Self-citationSex Differences in UDP-Glucuronosyltransferase 2B17 Expression and Activity
Gallagher, C. J., Balliet, R. M., Sun, D., Chen, G., & Lazarus, P. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035345 · Cited by 79
Glucuronidation of trans -resveratrol by human liver and intestinal microsomes and UGT isoforms
Brill, S., Furimsky, A. M., Ho, M. N., Furniss, M. J., Li, Y., Green, A. G., Green, C. E., Iyer, L., Bradford, W. W., & Kapetanović, I. M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.4.0006 · Cited by 77
Wang, S. W. J., Chen, J., Jia, X., Tam, V. H., & Hu, M. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009910 · Cited by 76
Self-citationBlevins‐Primeau, A. S., Sun, D., Chen, G., Sharma, A. K., Gallagher, C. J., Amin, S., & Lazarus, P. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3708 · Cited by 75
Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
Fujita, K.-I., & Sparreboom, A. (2010) · Current Clinical Pharmacology · doi:10.2174/157488410791498806 · Cited by 73
Emoto, C., Murayama, N., Rostami‐Hodjegan, A., & Yamazaki, H. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233503 · Cited by 73
Kerdpin, O., Mackenzie, P. I., Bowalgaha, K., Finel, M., & Miners, J. O. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028225 · Cited by 72
Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 Model
Jeong, E. J., Lin, H., & Hu, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063925 · Cited by 72
Self-citationJäger, W. R., Zembsch, B., Wolschann, P., et al. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00152-0 · Cited by 71
Sorich, M. J., Smith, P. A., McKinnon, R. A., & Miners, J. O. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00008 · Cited by 70
Zhou, J., Tracy, T. S., & Remmel, R. P. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028712 · Cited by 68
Dalvie, D., Kang, P., Zientek, M. A., Xiang, C. D., Zhou, S., & Obach, R. S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800323w · Cited by 66
Liang, S., Ge, G., Liu, H., Zhang, Y., Wang, L.-M., Zhang, J.-W., Lu, Y., Li, W., Fang, Z., Wu, J., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030734 · Cited by 64
Substrate specificity of the human UDP‐glucuronosyltransferase UGT2B4 and UGT2B7
Barré, L., Fournel‐Gigleux, S., Finel, M., Netter, P., Magdalou, J., & Ouzzine, M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05670.x · Cited by 60
Court, M. H. (2001) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1046/j.1365-2885.2001.00366.x · Cited by 60
Pang, Y., Nikolic, D. S., Zhu, D., Chadwick, L. R., Pauli, G. F., Farnsworth, N. R., & van Breemen, R. B. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600252 · Cited by 55
Sabolovic, N., Humbert, A., Radomińska‐Pandya, A., et al. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.498 · Cited by 55
Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity
Basu, N. K., Kovářová, M., Garza, A., Kubota, S., Saha, T., Mitra, P. S., Banerjee, R., Rivera, J., & Owens, I. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407872102 · Cited by 54
Insights on membrane topology and structure/function of UDP-glucuronosyltransferases
Magdalou, J., Fournel‐Gigleux, S., & Ouzzine, M. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903209270 · Cited by 53
Variability in the Oral Bioavailability of All-trans-Retinoic Acid
Adamson, P. C., Pitot, H. C., Balis, F. M., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.993 · Cited by 53
Basu, N. K., Kubota, S., Meselhy, M. R., Ciotti, M., Chowdhury, B., Hartori, M., & Owens, I. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401396200 · Cited by 51
Ogura, K., Ishikawa, Y. T., Kaku, T., Nishiyama, T., Ohnuma, T., Muro, K., & Hiratsuka, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.004 · Cited by 50
Wang, S. W. J., Kulkarni, K. H., Tang, L. Y., Wang, J. R., Yin, T., Daidoji, T., Yokota, H., & Hu, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147371 · Cited by 49
Self-citationTang, L. Y., Ye, L., Singh, R., Wu, B., Lv, C., Zhao, J., Liu, Z., & Hu, M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900223c · Cited by 48
Self-citationRamı́rez, J., Iyer, L., Journault, K., Bélanger, P., Innocenti, F., Ratain, M. J., & Guillemette, C. (2002) · Pharmaceutical Research · doi:10.1023/a:1015341726183 · Cited by 46
Jeong, E. J., Jia, X., & Hu, M. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0498852 · Cited by 46
Self-citationMorphine-6-glucuronide: potency and safety compared with morphine
van Dorp, E. L., Morariu, A. M., & Dahan, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.11.1955 · Cited by 45
Ruefer, C. E., Gerhäuser, C., Frank, N., et al. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500057 · Cited by 44
Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Li, C., & Wu, Q. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-69 · Cited by 44
Mechanism of stimulation of microsomal UDP-glucuronosyltransferase by UDP-N-acetylglucosamine
Bossuyt, X., & Blanckaert, N. J. C. (1995) · Biochemical Journal · doi:10.1042/bj3050321 · Cited by 42
Basu, N. K., Kole, L., & Owens, I. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00241-9 · Cited by 42
Davis, B. D., & Brodbelt, J. S. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.11.004 · Cited by 41
Joseph, T. B., Wang, S. W. J., Liu, X., Kulkarni, K. H., Wang, J., Xu, H., & Hu, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700135a · Cited by 41
Self-citationLocuson, C. W., & Tracy, T. S. (2007) · Xenobiotica · doi:10.1080/00498250601129109 · Cited by 40
Wu, B., Morrow, J. K., Singh, R., Zhang, S., & Hu, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175356 · Cited by 39
Self-citationSiissalo, S., Laine, L., Tolonen, A., Kaukonen, A. M., Finel, M., & Hirvonen, J. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.044 · Cited by 39
Starlard‐Davenport, A., Xiong, Y., Bratton, S. M., Gallus‐Zawada, A. E., Finel, M., & Radominska-p, A. (2006) · Steroids · doi:10.1016/j.steroids.2006.11.016 · Cited by 38
Position preference on glucuronidation of mono-hydroxylflavones in human intestine
Li, Z., Lin, G., & Zuo, Z. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.038 · Cited by 38
Wong, Y. C., Zhang, L., Lin, G., & Zuo, Z. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903179300 · Cited by 36
Wang, F. M., Yao, T.-W., & Zeng, S. (2003) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190482 · Cited by 35
Emodin Pharmacokinetics in Rabbits
Liang, J., Hsiu, S., Wu, P., & Chao, P. (1995) · Planta Medica · doi:10.1055/s-2006-958125 · Cited by 35
Basu, N. K., Kole, L., Basu, M., Chakraborty, K., Mitra, P., & Owens, I. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800032200 · Cited by 34
Sun, H., Li, Z., Chow, E. C. Y., Lin, G., Zuo, Z., & Pang, K. S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.137463 · Cited by 32
Fujiwara, R., Nakajima, M., Yamamoto, T., Nagao, H., & Yokoi, T. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.235 · Cited by 29
Lee-Hilz, Y. Y., Stolaki, M., van Berkel, W. V., Aarts, J., & Rietjens, I. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.02.010 · Cited by 28
Crespy, V., Nancoz, N., Oliveira, M., Hau, J., Courtet‐Compondu, M., & Williamson, G. (2004) · Free Radical Research · doi:10.1080/10715760410001728424 · Cited by 26
Volak, L. P., & Court, M. H. (2010) · Xenobiotica · doi:10.3109/00498251003596817 · Cited by 24
Cited by
The Effects of Flavonoids in Cardiovascular Diseases
Ciumărnean, L., Milaciu, M. V., Runcan, O., Vesa, Ș. C., Răchișan, A. L., Negrean, V., Perné, M.-G., Donca, V. I., Alexescu, T.-G., Para, I., et al. (2020) · Molecules · doi:10.3390/molecules25184320 · Cited by 444
Phenolic compounds: their journey after intake
Velderrain-Rodríguez, G. R., Palafox-Carlos, H., Wall-Medrano, A., Ayala-Zavala, J. F., Chen, C.-Y. O., Robles-Sánchez, M., Astiazaran-García, H., Alvarez-Parrilla, E., & González-Aguilar, G. A. (2014) · Food Funct. · doi:10.1039/c3fo60361j · Cited by 399
Bioavailability of phytochemicals and its enhancement by drug delivery systems
Aqil, F., Munagala, R., Jeyabalan, J., & Vadhanam, M. V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.032 · Cited by 398
Role of Polyphenols and Other Phytochemicals on Molecular Signaling
Upadhyay, S., & Dixit, M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/504253 · Cited by 376
Unraveling Anthocyanin Bioavailability for Human Health
Lila, M. A., Burton-Freeman, B., Grace, M., & Kalt, W. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033346 · Cited by 309
Metadata
- Authors
- Wu, B., Kulkarni, K., Basu, S., Zhang, S., & Hu, M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 100
- Issue
- 9
- Pages
- 3655-3681
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2064931573
- Cited by
- 309
- References
- 153
- FWCI
- 19.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.